|
The FDA monitors the marketplace for unapproved use of steroids and other substances that claim to have anabolic effects on the body, and takes action to prevent the sale of these illegal substances. ("Anabolic" refers to a substance's ability to stimulate muscle growth.) In its latest action, on March 9, 2006, the FDA issued warnings to several manufacturers of steroid products. "FDA takes its responsibility to protect Americans from dangerous unapproved |
|
drugs seriously. Today's action is indicative of our resolve," said Margaret O'K. Glavin, FDA's Associate Commissioner for Regulatory Affairs, in announcing the warnings. Some of the problems associated with anabolic steroids include: liver toxicity, shrunken testicles and male infertility, masculinization of women, breast enlargement in males, short stature in children, and a potential to increase the risk of heart attack and stroke. |
|